Related Experiment Video
Updated: May 2, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
The lipopeptide antibiotic paenibacterin binds to the bacterial outer membrane and exerts bactericidal activity
1Department of Food Science and Technology, The Ohio State University, Columbus, Ohio, USA.
Abstract:
Paenibacterin is a broad-spectrum lipopeptide antimicrobial agent produced by Paenibacillus thiaminolyticus OSY-SE. The compound consists of a cyclic 13-residue peptide and an N-terminal C15 fatty acyl chain. The mechanism of action of paenibacterin against Escherichia coli and Staphylococcus aureus was investigated in this study. The cationic lipopeptide paenibacterin showed a strong affinity for the negatively charged lipopolysaccharides (LPS) from the outer membrane of Gram-negative bacteria. Addition of LPS (100 μg/ml) completely eliminated the antimicrobial activity of paenibacterin against E. coli. The electrostatic interaction between paenibacterin and LPS may have displaced the divalent cations on the LPS network and thus facilitated the uptake of antibiotic into Gram-negative cells. Paenibacterin also damaged the bacterial cytoplasmic membrane, as evidenced by the depolarization of membrane potential and leakage of intracellular potassium ions from cells of E. coli and S. aureus. Therefore, the bactericidal activity of paenibacterin is attributed to disruption of the outer membrane of Gram-negative bacteria and damage of the cytoplasmic membrane of both Gram-negative and Gram-positive bacteria. Despite the evidence of membrane damage, this study does not rule out additional bactericidal mechanisms potentially exerted by paenibacterin.
Insights
Paenibacterin, a lipopeptide antimicrobial, targets bacterial membranes. It disrupts the outer membrane of Gram-negative bacteria and damages the cytoplasmic membrane of both Gram-negative and Gram-positive bacteria.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Paenibacterin is a broad-spectrum lipopeptide antimicrobial produced by Paenibacillus thiaminolyticus OSY-SE.
- It features a cyclic 13-residue peptide linked to a C15 fatty acyl chain.
Purpose of the Study:
- To investigate the mechanism of action of paenibacterin against Escherichia coli (Gram-negative) and Staphylococcus aureus (Gram-positive).
Main Methods:
- Assessing paenibacterin's interaction with lipopolysaccharides (LPS) from E. coli.
- Evaluating the effect of LPS on antimicrobial activity.
- Measuring bacterial membrane potential depolarization and intracellular potassium ion leakage.
Main Results:
- Paenibacterin exhibits strong affinity for negatively charged LPS in Gram-negative bacteria, with LPS addition neutralizing its activity against E. coli.
- Electrostatic interaction with LPS may facilitate antibiotic uptake into Gram-negative cells.
- Paenibacterin causes cytoplasmic membrane damage in both E. coli and S. aureus, indicated by membrane depolarization and potassium ion leakage.
Conclusions:
- Paenibacterin's bactericidal activity stems from outer membrane disruption in Gram-negative bacteria and cytoplasmic membrane damage in both Gram-negative and Gram-positive bacteria.
- Additional bactericidal mechanisms may also be involved.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Bacterial Toxins
Inhibitors of Bacterial Protein Synthesis
Bacterial Cell Wall
Biological Methods for Microbial Control

